Not recruiting yet
the Clinical Efficacy of Robotic and Laparoscopic Radical Total Gastrectomy in Locally Advanced Middle and Upper Gastric Cancer
NCT05235932 · Fujian Medical University · Updated 11 Feb 2022
- What is being tested
- Robotic radical total gastrectomy with D2 lymphadenectomy; Laparoscopic radical total gastrectomy with D2 lymphadenectomy
- For
- Gastric Cancer; Robotic Gastrectomy
- Kind of study
- Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
- Who can join
- Ages 18 years to 75 years. About 570 people. The full rules are on the registry page.
- Where
- China
- When
- Starts or started 20 Feb 2022, ends 20 Feb 2027. Registered 11 Feb 2022.
- Results
- None posted yet.
In the researchers' words
To evaluate the clinical efficacy (safety, feasibility and long-term efficacy) of robotic radical total gastrectomy and laparoscopic radical total gastrectomy in patients with locally advanced middle and upper gastric adenocarcinoma (CT2-4A, N-/+, M0) .
Sites
- Fujian Medical University Union HospitalFuzhou, Fujian, China